MedPath

The investigation of the therapeutic efficacy of rapid intravenous immunoglobulin injection for acute phase Kawasaki disease

Not Applicable
Conditions
Kawasaki disease
Registration Number
JPRN-UMIN000014665
Lead Sponsor
Jichi Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open public recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Kawasaki disease patients who are scheduled IVIG treatment

Exclusion Criteria

Patients with hypersensitivity to immunoglobulin.
Patients with cardiac or liver dysfunction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath